EY Accounting Technical webcast
Revenue recognition standard for life sciences
Hosted by EY Global Life Sciences sector
How will the new revenue recognition standard affect life sciences companies, and how should companies plan for implementation? Although we now have a clearer understanding of the implementation issues that companies are facing, how best to address these challenges is still evolving.
Join us for this webcast on 15 June as our panelists explore the revenue recognition implementation issues for pharma, biotech and medtech companies. The discussion will include:
- An update on the standard and potential changes being considered by the Transition Resource Group
- Practical application issues specific for life sciences companies
- Implementation challenges including project set up, contract selection and use of tools
The webcast will be hosted by Scott Bruns, EY Global Life Sciences Assurance Leader.
- Derek Kosti, Senior Director of Finance and Worldwide Controller at Pfizer Inc.
- Tim Gordon, EY Global Life Sciences Financial Accounting Advisory Services Leader
- Frederik Schmachtenberg, EY Global Life Sciences Assurance Resident